00

Guilin Sanjin Pharmaceutical Co Ltd

002275 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

14.36CNY-1.59 (-9.97%)

Price History

Full chart

Market Stats

Previous Close15.95
Open15.40
Day Range14.36 – 15.58
52-Week Range11.91 – 15.20
Volume39.36M
Market Cap7.18B
P/E (TTM)17.71
Forward P/E19.96
EPS0.69
Dividend Yield4.09%
Beta0.16
50-Day Avg12.76
200-Day Avg13.64

About

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, manufacturing, and sale of traditional Chinese medicines in China and internationally. The company offers Sanjin Tablets, Sanjinpian, Guilin Watermelon Frost, Watermelon Frost Throat Lozenges, Guilin Watermelon Frost Lozenges, Watermelon Frost Throat Clearing Lozenges, Vertigo Relief Tablets/Granules, Gecko Asthma Relief Capsules, Lamotrigine Tablets (Anxian), Naomaitai Capsules, Yuye Detoxification Granules, and Compound Tianqi Stomach Pain Capsules, Soothing Throat Spray, Guilin Watermelon Frost Capsules, NaoMaiTai Capsules, Dizziness Relief Granules, Sanqi Blood Damage Relief Capsules, Sanqi Blood Injury Relief Powder, Compound Luo Han Guo Lung-Clearing Granules, Compound Monk Fruit Lung-Clearing Syrup, Compound Red Root Herb Tablets, Shuanghu Swelling and Pain Relief, Liver and Kidney Tonifying Granules, and Jade Leaf Detoxification Granules. Its products are used in various therapeutic areas, such as urinary system diseases, oral and pharyngeal medications, throat medication, cardiovascular and cerebrovascular disease medications, nervous system diseases, respiratory disease, digestive system disease, internal medicine drugs, musculoskeletal system diseases, and tonifying drugs. Guilin Sanjin Pharmaceutical Co., Ltd. was incorporated in 2001 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Xun Zou
  • Employees2.56K
  • HeadquartersNo. 9, Renmin South Road, Guilin, China, 541199, China
  • Websitehttps://www.sanjin.com.cn

Leadership

  • Mr. Xun ZouChairman of the Board & President · b. 1976
  • Mr. Chun LiFinancial Officer, VP & Secretary of the Board · b. 1977
  • Mr. Jinqian XuPersonnel Administration Director, Manager of HR Mgmt. Dept. & Director · b. 1971
  • Mr. Zhun ZouVP & Non-Independent Director · b. 1980
  • Mr. Jingdu LeiDirector & VP · b. 1970
  • Jie ZengAccounting Supervisor

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue797.85M893.05M986.16M1.11B983.46M1.16B1.31B1.47B1.47B1.39B1.53B1.62B1.58B1.64B1.57B1.74B1.96B2.17B2.19B2.05B
Growth (%)-+11.93%+10.43%+12.64%-11.47%+18.13%+12.89%+12.03%-0.20%-5.14%+9.66%+5.95%-1.94%+3.52%-4.51%+11.15%+12.55%+10.81%+1.03%-6.76%
Cost of Revenue238.08M243.99M253.36M255.07M272.09M330.97M387.80M406.45M415.12M384.60M410.21M389.26M432.43M445.36M449.25M457.04M574.37M602.57M610.47M490.41M
Gross Profit559.77M649.05M732.80M855.76M711.37M830.81M923.75M1.06B1.05B1.01B1.12B1.23B1.15B1.20B1.12B1.28B1.39B1.57B1.58B1.56B
Gross Margin70.16%72.68%74.31%77.04%72.33%71.51%70.43%72.34%71.69%72.35%73.10%75.91%72.71%72.85%71.32%73.75%70.69%72.25%72.18%76.03%
Operating Expense329.30M359.88M397.95M489.68M410.14M493.06M540.40M575.93M527.80M582.41M647.63M662.10M653.99M725.65M762.50M855.15M938.58M1.05B938.75M987.18M
Operating Income230.47M289.18M334.85M366.08M301.23M337.75M383.35M486.95M523.43M423.92M467.39M564.66M498.26M469.42M354.74M429.04M446.78M518.26M644.77M568.15M
Operating Margin28.89%32.38%33.96%32.96%30.63%29.07%29.23%33.14%35.70%30.48%30.64%34.94%31.44%28.62%22.65%24.64%22.80%23.87%29.39%27.77%
EBITDA250.64M317.90M358.66M390.48M343.36M392.03M411.65M499.58M528.31M462.50M514.63M592.05M552.75M556.17M393.58M412.97M412.21M575.53M571.42M656.12M
EBITDA Margin31.41%35.60%36.37%35.15%34.91%33.74%31.39%34.00%36.03%33.25%33.74%36.64%34.88%33.90%25.12%23.72%21.03%26.50%26.04%32.07%
Net Income194.80M249.18M273.73M302.53M258.76M291.95M331.15M421.99M444.87M376.53M393.66M464.40M413.35M392.14M277.02M343.72M329.53M421.30M521.53M433.13M
Net Income Margin24.42%27.90%27.76%27.23%26.31%25.13%25.25%28.72%30.34%27.07%25.81%28.74%26.08%23.90%17.68%19.74%16.81%19.40%23.77%21.17%
R&D-------12.85M45.16M56.82M65.63M58.18M64.67M104.11M154.28M202.45M217.04M158.06M173.29M160.04M
R&D as % of Total Revenue-------0.87%3.08%4.09%4.30%3.60%4.08%6.35%9.85%11.63%11.07%7.28%7.90%7.82%
Interest Expense1.26M4.76M7.33M5.73M1.52M137.44K2.95M2.60M4.27M5.71M5.57M2.16M5.53M5.77M11.55M18.98M20.58M16.70M14.09M19.86M
Interest Expense % of Total Revenue0.16%0.53%0.74%0.52%0.15%0.01%0.22%0.18%0.29%0.41%0.37%0.13%0.35%0.35%0.74%1.09%1.05%0.77%0.64%0.97%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets831.81M1.08B1.17B2.06B1.98B2.20B2.49B2.69B2.78B2.76B2.87B3.23B3.41B3.42B3.88B4.10B3.96B3.94B4.23B4.26B
Total Liabilities204.48M349.58M378.65M279.00M181.47M218.18M407.26M486.11M463.07M416.59M444.26M575.65M599.47M600.18M923.27M1.26B1.15B1.12B1.22B1.07B
Total Equity619.17M720.78M778.26M1.77B1.79B1.98B2.08B2.20B2.32B2.34B2.43B2.65B2.81B2.82B2.96B2.84B2.81B2.82B3.01B3.19B
Cash197.39M379.58M306.06M1.15B1.07B1.17B1.04B690.18M626.30M706.89M719.82M733.52M1.22B1.17B1.36B1.48B1.27B1.06B1.05B990.99M
Total Debt8.81M179.00M178.10M26.10M1.10M1.10M1.10M21.10M50.00M50.00M50.00M100.00M100.00M184.23M399.54M609.10M465.88M409.07M475.61M-
Net Debt-188.58M-200.58M-127.96M-1.12B-1.07B-1.17B-1.04B-669.08M-576.30M-656.89M-669.82M-633.52M-1.12B-984.34M-962.37M-868.58M-799.83M-529.77M-573.99M-

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow217.67M164.39M190.97M363.29M285.49M341.05M302.59M314.16M396.53M398.50M536.85M387.82M551.73M468.29M597.99M410.24M528.67M549.25M588.33M708.12M
Investing Cash Flow-35.42M-9.79M-34.29M-50.64M-82.24M-145.89M-199.80M-385.05M-166.21M37.61M-252.91M-185.45M195.52M-673.56M-207.96M-146.97M-80.24M-94.22M-349.41M-
Financing Cash Flow-65.35M17.40M-232.53M524.12M-260.32M-101.12M-233.80M-275.59M-298.25M-355.52M-295.84M-188.48M-263.42M-344.10M-81.90M-319.89M-682.78M-361.57M-208.31M-
Capital Expenditure29.16M17.59M38.64M54.68M98.44M126.75M205.63M312.85M211.28M125.02M65.36M61.53M89.96M226.14M205.47M144.09M62.27M76.40M82.18M86.94M
Free Cash Flow188.51M146.80M152.33M308.61M187.05M214.30M96.96M1.31M185.25M273.48M471.49M326.29M461.76M242.14M392.52M266.15M466.40M472.85M506.16M621.18M
Dividends Paid50.35M151.60M227.13M177.36M251.22M100.02M239.00M295.59M326.51M356.82M296.57M240.56M238.91M203.88M132.31M460.22M528.81M427.77M336.14M341.05M
FCF to OCF86.60%89.30%79.77%84.95%65.52%62.84%32.04%0.42%46.72%68.63%87.83%84.13%83.69%51.71%65.64%64.88%88.22%86.09%86.03%87.72%
Dividend Paid to FCF26.71%103.27%149.11%57.47%134.31%46.67%246.51%22496.29%176.26%130.48%62.90%73.72%51.74%84.20%33.71%172.92%113.38%90.47%66.41%54.90%

Earnings

Report DateDec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013Apr 24, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 7, 2014Oct 23, 2014Feb 16, 2015Apr 27, 2015Aug 20, 2015Oct 27, 2015Feb 27, 2016Apr 21, 2016Aug 21, 2016Oct 21, 2016Feb 24, 2017Apr 26, 2017Aug 22, 2017Oct 25, 2017Apr 20, 2018Aug 22, 2018Oct 21, 2018Dec 31, 2018Apr 23, 2019Aug 28, 2019Oct 24, 2019Apr 28, 2020Aug 26, 2020Oct 30, 2020Apr 29, 2021Aug 27, 2021Oct 29, 2021Apr 27, 2022Aug 19, 2022Oct 29, 2022Apr 27, 2023Aug 24, 2023Oct 29, 2023May 16, 2024Aug 29, 2024Oct 29, 2024Apr 25, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------0.12----------------------------------------------
EPS Actual0.130.080.170.110.070.090.190.120.090.110.210.140.100.120.240.160.180.120.280.160.200.090.280.110.160.120.260.150.130.130.300.160.140.320.160.080.150.320.100.110.290.110.170.260.080.090.310.040.290.360.030.040.340.140.180.310.170.080.210.23
Surprise-------------0.00%----------------------------------------------
Timing-------------After-hours----After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-market-Pre-market--------Pre-market--Pre-marketAfter-hoursPre-marketAfter-hours-Pre-marketPre-market-----

Key Statistics & Ratios

Market Cap7.18B
Enterprise Value6.09B
Trailing P/E17.71
Forward P/E19.96
Price / Sales3.56
Price / Book2.20
EPS0.69
Book Value5.56
Revenue (TTM)2.02B
Gross Profit (TTM)1.51B
EBITDA592.24M
Profit Margin20.19%
Operating Margin32.82%
Return on Equity12.73%
Return on Assets7.21%
Shares Outstanding587.57M
Shares Float134.62M
Beta0.16
Dividend Yield4.09%
Dividend Rate0.50
Payout Ratio72.19%

Dividends

20262×
0.15Nov 11, 20260.30Jun 4, 2026
20252×
0.20Nov 19, 20250.35May 30, 2025
20242×
0.25Nov 26, 20240.30May 29, 2024
20232×
0.30Nov 27, 20230.40May 31, 2023
20222×
0.40Dec 1, 20220.50May 30, 2022
20212×
0.40Nov 25, 20210.40Jun 1, 2021
20201×
0.23Jun 1, 2020
20191×
0.35May 31, 2019
20181×
0.40May 24, 2018
20171×
0.40Jun 12, 2017
20161×
0.50Jun 2, 2016
20151×
0.60Jun 2, 2015
20141×
0.55Apr 29, 2014
20131×
0.50Apr 24, 2013
20121×
0.40May 16, 2012
20111×
0.22Apr 21, 2011
20101×
0.42Mar 18, 2010

Stock Splits

  • Apr 21, 201113:10